Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK-0518 and Depakote for Latent HIV Depletion
NCT00614458Phase 2Terminated
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Apr 2007
- Primary completion
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of raltegravir, divalproex sodium in human immunodeficiency virus infection (HIV), sponsored by University of North Carolina at Chapel Hill. Started Apr 2007; status: terminated.
02
Drugs
raltegravirdivalproex sodium
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00614458.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00614458.